Mediso

Budapest, Hungary Founded: 1990 • Age: 36 yrs
Nuclear medicine and hybrid imaging equipment

About Mediso

Mediso is a Healthcare company based in Budapest (Hungary) founded in 1990. It operates as a nuclear medicine and hybrid imaging equipment. Mediso has completed 1 acquisition, including Bartec Technologies. Mediso offers products and services including AnyScan® TRIO SPECT/CT, nanoScan® SPECT/CT, and nanoScan® PET/CT. Its focus areas include Life Sciences, Imaging Diagnostics and Nuclear Imaging. Its legal entity is Mediso Ltd. Its competitors include Mercurius Health, Niowave, Clear Vascular, PETsys Electronics and Cubresa and 4 more; 4 of its 9 listed competitors have raised funding.

Company details

Mediso develops nuclear medicine and hybrid imaging equipment. Products developed by the company include AnyScan (triple-modality SPECT-CT-PET clinical system, as well as various single or multi-detector SPECT products), Nucline (gamma camera and processing workstations for planar and SPECT imaging), nanoScan (two MRI and two CT based bimodal solutions), and NanoSPECTCT imaging units.

  • Headquarters Budapest, Hungary
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website mediso.com
  • Social LinkedIn Facebook
  • Legal Name Mediso Ltd
Operational Areas
Key Metrics

Products & Services of Mediso

Mediso offers a comprehensive portfolio of products and services, including AnyScan® TRIO SPECT/CT, nanoScan® SPECT/CT, and nanoScan® PET/CT.

AnyScan® TRIO SPECT/CT
Clinical Imaging System

Delivers theranostic and diagnostic imaging for nuclear medicine applications.

nanoScan® SPECT/CT
Preclinical Imaging System

Provides versatile SPECT/CT for research and quantitative imaging.

nanoScan® PET/CT
Preclinical Imaging System

Enables real dynamic PET studies for quantitative research purposes.

Funding Insights of Mediso

  • Total Rounds 2
  • Last Round Grant — $317,419
  • First Round $939,020

    (Oct 2017)

  • Investors Count 1

All 2 funding rounds of Mediso with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2023$317,419Grant––
Oct 2017$939,020Grant––
Valuation history

1 investors in total: 1 institutional.

Investors in Mediso

Mediso has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for Mediso

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Mediso

Mediso has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Bartec Technologies.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Mediso: Advanced medical imaging systems and radioactive sources
bartectechnologies.comFarnborough, United Kingdom1998May 2022••••
Premium access

Complete acquisition details for Mediso

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Mediso

4 dated milestones of Mediso across 33 years, from founding to its latest funding, stage changes and deals.

  1. Founded Mediso is founded.
  2. Funding First funding round of $939K.
  3. Acquisition Acquires Bartec Technologies.
  4. Funding Latest funding round, Grant, of $317K.

Competitors of Mediso

Mediso has 9 listed competitors in our database, 4 of them funded. They include Mercurius Health, Niowave, Clear Vascular, PETsys Electronics and Cubresa, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
mercuriushealth.com2013Porto Salvo, Portugal––
Resources and training for radiotherapy and nuclear medicine are provided.
niowaveinc.com2006United States$9.95M–
Devices and radioisotopes for nuclear imaging are provided by Niowave.
clearvascular.com2005The Woodlands, United States$3.16M–
Develops pharmaceutical products for treating cardiovascular conditions.
petsyselectronics.com2013Oeiras, Portugal––
Gamma ray detectors are developed for medical PET scanners.
cubresa.com2011Winnipeg, Canada$4.5M–
Nuclear imaging products
cmr-naviscan.com2003Carlsbad, United States––
High-resolution PET systems for breast cancer imaging are provided.
bestcyclotron.com2009–––
Provides comprehensive design and production solutions for commercial cyclotrons.
seraclifesciences.com2017London, United Kingdom$2.04M–
Molecular imaging devices are developed for arthritis diagnostics.
gmisotope.com2013Henderson, United States––
Specializes in medical isotope production and specialty metal processing.
Premium access

Detailed competitors of Mediso

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Mediso

The website of Mediso (mediso.com) receives about 4.1K visits a month.

  • Monthly visits
    4.1K

    ▼ 4.4% vs previous month

Similar websites

Websites whose visitors overlap most with Mediso. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
ultrasoundportables.com
ultrasoundportables.com
100%
–#1,991,920–
labtechinc.com
labtechinc.com
92%
–#11,786,485–

Top companies in Imaging Diagnostics

10 companies that operate in the same segment as Mediso (Imaging Diagnostics), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Handheld ultrasound devices are developed for whole-body medical imaging.
2011Guilford, Connecticut, United StatesUSD 350 MUSD 97.61 M464
Technology tools and systems for molecular scale are developed.
1959Abingdon, Oxfordshire, United Kingdom–USD 648.1 M–
MR-interfaced ultrasound devices for cancer and neurology treatments are provided.
1999Tirat Carmel, Haifa District, IsraelUSD 574.2 M–541
Robotic microsurgical systems for endoscopy are developed.
2007Redwood City, California, United StatesUSD 733.62 M–91
Manufacturer of imaging and surgical products
1919Tokyo, Tokyo, Japan–USD 6.49 B35,933
Ultrasound images are analyzed via AI-based software provided by Exo.
2015Redwood City, California, United StatesUSD 463.39 M––
Planar X-ray radiology products for diagnostic imaging are supplied.
2000Oxford, Oxfordshire, United KingdomUSD 43.43 MUSD 1.04 M50
Digital X-ray sources are developed by Nanox for cloud-based diagnostics.
2004Jerusalem, Jerusalem District, IsraelUSD 110.72 MUSD 13.02 M165
ImaginAb is focused on developing advanced immuno-oncology imaging technologies.
2007Los Angeles, California, United StatesUSD 59.64 M––
Portable wireless ultrasound systems are developed for medical imaging.
2014Burnaby, British Columbia, CanadaUSD 21.87 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • âś“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • âś“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • âś“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Mediso

Premium access

Complete news archive for Mediso

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mediso

Mediso was founded in 1990 and raised its 1st funding round 27 years after it was founded.

Mediso is headquartered in Budapest, Hungary.

Mediso develops nuclear medicine and hybrid imaging equipment. Products developed by the company include AnyScan (triple-modality SPECT-CT-PET clinical system, as well as various single or multi-detector SPECT products), Nucline (gamma camera and processing workstations for planar and SPECT imaging), nanoScan (two MRI and two CT based bimodal solutions), and NanoSPECTCT imaging units.

Mediso's top competitors include Niowave, Cubresa and Mercurius Health.

Mediso offers AnyScan® TRIO SPECT/CT, nanoScan® SPECT/CT, and nanoScan® PET/CT.

Mediso has made 1 acquisition, including Bartec Technologies.

Mediso has 1 investor. Key investors include European Union.

Mediso operates through Mediso Ltd.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available